Anzeige
Meldung des Tages: Dieses US-Kupferprojekt geht jetzt mit 10.000 Fuß Bohrungen in die Umsetzungsphase

Penumbra News

Aktie
WKN:  A14Y65 ISIN:  US70975L1070 US-Symbol:  PEN Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
343,13 $
-1,18 $
-0,34%
293,01 € 20:36:21 Uhr
Depot/Watchlist
Marktkapitalisierung *
10,43 Mrd. €
Streubesitz
-
KGV
659,67
Nachhaltigkeits-Score
42 %
Index-Zuordnung
-

Penumbra News

25.02.26 - PR Newswire
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results PR Newswire
04.02.26 - PR Newswire
Boston Scientific announces results for fourth quarter and full year 2025
Boston Scientific announces results for fourth quarter and full year 2025 PR Newswire
28.01.26 - PR Newswire
Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights PR Newswire
28.01.26 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA PR Newswire
21.01.26 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS PR Newswire
21.01.26 - PR Newswire
Halper Sadeh LLC Encourages PEN, FONR, GDOT Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages PEN, FONR, GDOT Shareholders to Contact the Firm to Discuss Their Rights PR Newswire
16.01.26 - PR Newswire
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN PR Newswire
15.01.26 - PR Newswire
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Penumbra, Inc. (NYSE: PEN)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Penumbra, Inc. (NYSE: PEN) PR Newswire
15.01.26 - PR Newswire
Shareholder Alert: The Ademi Firm investigates whether Penumbra, Inc. is obtaining a Fair Price for its Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether Penumbra, Inc. is obtaining a Fair Price for its Public Shareholders PR Newswire
15.01.26 - PR Newswire
Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results
Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results PR Newswire
15.01.26 - PR Newswire
Boston Scientific announces agreement to acquire Penumbra, Inc.
Boston Scientific announces agreement to acquire Penumbra, Inc. PR Newswire
29.12.25 - PR Newswire
Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire
19.11.25 - PR Newswire
Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference
Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference PR Newswire
05.11.25 - PR Newswire
Penumbra, Inc. Reports Third Quarter 2025 Financial Results
Penumbra, Inc. Reports Third Quarter 2025 Financial Results PR Newswire
03.11.25 - PR Newswire
Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism
Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with ...
27.10.25 - PR Newswire
Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism
Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment ...
08.10.25 - PR Newswire
Penumbra, Inc. Schedules Investor Event at TCT Conference on October 26, 2025; Earnings Release and Conference Call for Third Quarter 2025 Scheduled for November 5, 2025
Penumbra, Inc. Schedules Investor Event at TCT Conference on October 26, 2025; Earnings Release and Conference Call for Third Quarter 2025 Scheduled for November 5, 2025 ...
09.09.25 - PR Newswire
New Survey Shows Management of Blood Clots is Inconsistent, Even for Patients with the Same Risk Profile
New Survey Shows Management of Blood Clots is Inconsistent, Even for Patients with the Same Risk Profile PR Newswire
27.08.25 - PR Newswire
Penumbra, Inc. Names Shruthi Narayan as Company President
Penumbra, Inc. Names Shruthi Narayan as Company President PR Newswire
20.08.25 - PR Newswire
Penumbra, Inc. to Present at Upcoming Investor Conferences
Penumbra, Inc. to Present at Upcoming Investor Conferences PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr -4,34%
Technical Trading: Limit für das Pfund!
GBP/USD Long Typ: Open End Turbo WKN: VV7D1E Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »